Recombinant human erythropoietins (rHuEPO) are erythropoiesis-stimulating agents (ESA) used in the treatment of anemia resulting from chronic kidney disease, ... |
These drugs are licensed for the treatment of anemia associated with chronic renal failure, chemotherapy for nonmyeloid cancers, zidovudine treatment of HIV, ... |
Recombinant human erythropoietins are given to patients with kidney failure to treat anemia. List of Recombinant human erythropoietins. View by Generic | Brand. |
Recombinant human erythropoietin (EPO) may be a promising neuroprotective/neuroregenerative treatment of MS. In the nervous system, EPO acts anti-apoptotic, ... |
13 июн. 2023 г. · Yes, Recombinant Human Erythropoietin Alfa is used to treat anemia caused due to chronic kidney disease in children who are above 1 year of age. |
Erythropoietin is a recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
This review describes some of the physiological effects of recombinant human erythropoietin (EPO) in healthy humans. At the blood level EPO increases the ... |
It contains Recombinant Human Erythropoietin Alfa used to treat anaemia caused by chronic diseases and anaemia related to kidney disease, cancers, bone marrow ... |
25 авг. 2020 г. · The present study aimed to study the protective effect of intranasally delivered recombinant human erythropoietin (rhEPO) on cognitive and ... |
Запросы по теме
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |